“Carbuncle”的搜索结果，显示 171-180 项，共有 5259 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients ...

6. 微创手术治疗- 医生与科室- 妙佑医疗国际

   科室与专家门诊. 妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心 ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...